Biotech Values

[DewDiligence]

>A poster on another Board (RPRX, naturally) mentioned that MNTA would never be able to get around Teva's patent, totally ignoring that Sanofi's Lovenox patent is, in all likelihood, being negated as we speak by Teva!<

It’s astonishing that someone can be so clueless about the pharma business. The fact is: nearly every big-selling non-biologic drug has already had its patent challenged or soon will. Moreover, the KSR decision by the US Supreme Court makes it considerably easier for a challenger to prevail (#msg-19404785).